Cohort1: AZD8233_dose level1
|
Administration route |
subcutaneous injection |
Dosage |
AZD8233, 4 mg, single dose, on Day 1 |
Age |
Adult |
References |
PMID:
38504437
|
|
Cohort2: AZD8233_dose level2
|
Administration route |
subcutaneous injection |
Dosage |
AZD8233, 12 mg, single dose, on Day 1 |
Age |
Adult |
References |
PMID:
38504437
|
|
Cohort3: AZD8233_dose level3
|
Administration route |
subcutaneous injection |
Dosage |
AZD8233, 20 mg, single dose, on Day 1 |
Age |
Adult |
References |
PMID:
38504437
|
|
Cohort4: AZD8233_dose level4
|
Administration route |
subcutaneous injection |
Dosage |
AZD8233, 30 mg, single dose, on Day 1 |
Age |
Adult |
References |
PMID:
38504437
|
|
Cohort5: AZD8233_dose level5
|
Administration route |
subcutaneous injection |
Dosage |
AZD8233, 60 mg, single dose, on Day 1 |
Age |
Adult |
References |
PMID:
38504437
|
|
Cohort6: AZD8233_dose level6
|
Administration route |
subcutaneous injection |
Dosage |
AZD8233, 90 mg, single dose, on Day 1 |
Age |
Adult |
References |
PMID:
38504437
|
|
Cohort7: AZD8233_dose level7
|
Administration route |
subcutaneous injection |
Dosage |
AZD8233, 120 mg, single dose, on Day 1 |
Age |
Adult |
References |
PMID:
38504437
|
|
Cohort8: Placebo
|
Administration route |
subcutaneous injection |
Age |
Adult |
References |
PMID:
38504437
|
|